Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
FYI: The U.S. stock market’s blistering rally stretched into a fourth day, as the S&P 500 posted another all-time high. Not a ton of news out there on which to peg Monday’s move. Broadly, investors continue to shrug off the potential for a Federal Reserve interest rate hike next year. At the same time, though, many appear to anticipate additional central bank easing in Europe and elsewhere. Oil and natural-gas prices continued to slide, as did gold. Gilead Sciences (GILD) weighed on the health-care sector and biotech ETFs after falling 14%, that stock’s biggest one-day slide since January 2001. Regards, Ted http://blogs.barrons.com/focusonfunds/2014/12/22/etf-market-vital-signs-dec-22-onward-and-upward-except-gilead/tab/print/
